Canopy Growth Corp Jumped On NYSE Application

Analysis originally distributed on May 16, 2018 By: Michael Vodicka of Cannabis Stock Trades

Canadian cannabis stocks got a big jolt this week after an early industry leader announced it has applied for a listing on the New York Stock Exchange. This looks like the beginning of a new trend in the cannabis sector – and today I am going to reveal three strategies to potentially profit.

Canopy Growth Corp (TWMJF) announced on Monday that it has applied to be the first Canadian cannabis company to trade on the New York Stock Exchange.

Here are some more details from Bloomberg.

“Canada’s biggest marijuana company has applied to become the first pot producer to list on the New York Stock Exchange.

Canopy Growth Corp., which already trades on the Toronto Stock Exchange under the ticker symbol WEED, said Monday it expects its shares to begin trading in New York under the symbol CGC before the end of May.

Chief Executive Officer Bruce Linton said earlier this year that he was one day away from filing to list on the Nasdaq Stock Market but pulled back to focus on closing a deal with alcohol giant Constellation Brands Inc. He said Monday that he chose the NYSE over the Nasdaq because of the additional credibility it lends his company.”

Read the article, Canopy Applies to Become First Pot Producer Listed on the NYSE.

This is big news and another big-time win for the fast-growing cannabis industry.

Canopy is in position to be the first Canadian cannabis company listed on the New York Stock Exchange (NYSE). That should increase interest in Canopy and the broader cannabis sector.

Canopy’s potential uplisting to the NYSE also shows that the cannabis industry is quickly gaining a lot of credibility. The uplisting should trigger more capital inflows into the sector.

The good news sent the entire Canadian cannabis sector jumping higher. The Canadian cannabis index jumped more than 4%.

Canopy did even better – shares were up as much as 10% on the day.

Canopy is back within striking distance of a new 2018 high. Take a look.

Canopy Growth Corp

Looking forward – I am expecting more Canadian stocks to follow Canopy’s lead and pursuit listings on the NYSE.

Below I reveal three Canadian cannabis companies that I expect to apply for listings on large US stock exchanges such as the NYSE and the NASDAQ.

If that happens, just like Canopy, I am expecting shares to get a nice short-term jolt and gain long-term credibility.

Aurora Cannabis (ACBFF) is the second largest Canadian cannabis company and one of the largest in the world. Aurora has been on a buyout binge lately, buying multiple companies to help Aurora grow production as quickly as possible ahead of recreational going legal. Aurora is also building a massive cannabis greenhouse Called Aurora Sky. When completed Aurora Sky is set to be more than 1 million square feet.

Aphria Corp (OTC: APHQF) is also one of the largest Canadian cannabis companies. Aphria is making big moves to cash in on Canada’s high-growth recreational cannabis market. Aphria is building a 1 million square foot cannabis greenhouse that positions Aphria as a low-cost producer. Aphria continues to report excellent progress.

  • Aphria One – 700,000 square foot Part IV expansion project remains on-time, first sale continues to be expected in January 2019.
  • Aphria Diamond – 1,300,000 square foot retrofit project remains on-time, first sale continues to be expected in January 2019.
  • Broken Coast – Phase III expansion complete and awaiting Health Canada. Phase IV expansion project modified to increase capacity but moves first sale expectations to Fall 2019.

Organigram Holdings, Inc. (OGRMF) is a mid-sized Canadian cannabis company with a niche in organic cannabis. Organigram is already delivering impressive sales growth. The company reported awesome second-quarter results in late April. Sales jumped 123% from last year to $3.2 million. Net income increased to $1.1 million from a loss of $5 million last year. Phase 3 expansion of its new greenhouse is expected to be complete for the start of filling of rooms with first cannabis plants by June 1, 2018, bringing Organigram’s pro-forma run-rate capacity to 36,000 kg per year. Organigram plans to launch its adult-recreational brand strategy on or about May 15, 2018. And finally, Organigram expects to announce one or more strategic or international investments in the upcoming quarter.

Risks to Consider

The Canadian cannabis industry faces a key vote on June 7 to finalize plans to legalize recreational cannabis. The bill is expected to pass – and set the stage for legalization – but the pending vote is driving some caution.

Action to Take

These three companies are early leaders in Canada’s high-growth cannabis industry. Each of them are great candidates to follow in Canopy’s footsteps and apply for an uplisting onto a major US stock exchange such as the NYSE or NASDAQ. If that happens, I expect shares to jump higher in the short run and get a long-term boost.

Enjoy,

Michael Vodicka
Editor, Cannabis Stock Trades

The information contained in this post is for informational and educational purposes only. The trading ideas and stock selections represented on the Cannabis Stock Trades website are not tailored to your individual investment needs. Readers and members are advised to consult with their financial advisor before entering into any trade. Cannabis stocks carry a certain level of risk and we accept no responsibility for any potential losses. All trades, patterns, charts, systems, etc. discussed are for illustrative purposes only and not to be construed as specific advisory recommendations. All ideas and material presented are entirely those of the author and do not necessarily reflect those of the publisher.

Like analysis from Michael Vodicka of Cannabis Stock Trades?

To get the latest analysis as soon as it is released, please subscribe to our free weekly newsletter

Cannabis Stock Trades provides investors reliable information on the cannabis industry and the small group of hidden companies that are cashing in on this explosive trend.

Is This Australian Cannabis Stock A Winner?

Analysis originally distributed on May 2, 2018 By: Michael Vodicka of Cannabis Stock Trades

There are few things that can send a stock soaring like a buyout. Right now I see a wave of buyouts ready to pop off in the Australian cannabis sector- and I want to show you how you can profit. Let’s take a closer look.

Cann Group, Inc.(CNGGF) is an early industry leader in Australia’s high-growth cannabis market.

In 2017, it became the first Australian recipient of research & medicinal cannabis cultivation licenses and the only company to have licenses reissued for year two.

Since acquiring these permits, Cann Group has been investing millions into expanding production and medical research.

For example, Cann Group is building a new state of the art cannabis greenhouse and R&D center with the ability to grow thousands of pounds of cannabis every month.

Funding has been secured for all three stages of the project. This new facility will be the nucleus of Cann Group’s potential expansion across Australia.

Cann Group’s aggressive moves have attracted the attention of the world’s largest cannabis companies – and sent shares soaring. Continue reading "Is This Australian Cannabis Stock A Winner?"

My Plan For Another 30% Gain In 5 Days

Analysis originally distributed on March 7, 2018 By: Michael Vodicka of Cannabis Stock Trades

The Canadian cannabis sector scored another blockbuster win last week - and it led to a quick 30% gain for one of Canada's most promising young cannabis companies. If you missed the recent pop higher don't worry - I see this same pattern repeating itself at least a few more times in the next three months. Here's what is going on.

Cronos Group (CRON) is one of Canada's largest and most promising cannabis companies. Shares began trading on the Toronto Venture Stock Exchange in December of 2014. Since then, Cronos has delivered huge gains to shareholders, jumping more than 1400% from its IPO price of $.80.

That impressive performance helped Cronos make history last week when it became the first ever Canadian cannabis producer to trade on the US-based NASDAQ stock exchange. Continue reading "My Plan For Another 30% Gain In 5 Days"

North American Cannabis Index Jumps 86% in 2017

Analysis originally distributed on January 3, 2018 By: Michael Vodicka of Cannabis Stock Trades

2017 turned out to be a great year for cannabis stocks - particularly if you knew which stocks to buy.

The North American Cannabis Index was up 86% in 2017.

North American Marijuana Index

Canadian stocks were on fire - the Canadian Cannabis Index was up 160% in 2017.

Canadian Marijuana Index

Most improved award goes to US cannabis stocks - they were steadily falling for most of the year - down 40% on the year in late October.

Then in early November, a major rally kicked in and US cannabis stocks rallied hard - with the US cannabis index jumping more than 100% from the 52-week low. Continue reading "North American Cannabis Index Jumps 86% in 2017"

Aurora Delivers 2,500% Revenue Growth in 12 Months

Analysis originally distributed on May 19, 2017 By: Michael Vodicka of Cannabis Stock Trades

First-quarter earnings season is almost over.

And the cannabis sector has been knocking it out of the park.

A lot of the stocks that we have covered over the last few months have stepped up and delivered excellent results.

Let's take a closer look.

In terms of pure growth, the best report I've seen came from Aurora Cannabis (ACBFF), one of the largest medical cannabis companies in Canada

Revenue jumped 2,500% from the same period last year to $5.2 million and was up 33% from just last quarter. Continue reading "Aurora Delivers 2,500% Revenue Growth in 12 Months"